Logo image of TOI

ONCOLOGY INSTITUTE INC/THE (TOI) Stock Price, Quote, News and Overview

NASDAQ:TOI - Nasdaq - US68236X1000 - Common Stock - Currency: USD

0.8492  -0.03 (-3.5%)

After market: 0.84 -0.01 (-1.08%)

TOI Quote, Performance and Key Statistics

ONCOLOGY INSTITUTE INC/THE

NASDAQ:TOI (2/5/2025, 8:00:01 PM)

After market: 0.84 -0.01 (-1.08%)

0.8492

-0.03 (-3.5%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Providers & Services
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Facilities
Statistics
52 Week High2.1
52 Week Low0.13
Market Cap64.17M
Shares75.56M
Float60.51M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPO03-13 2020-03-13


TOI short term performance overview.The bars show the price performance of TOI in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 50 100 150 200

TOI long term performance overview.The bars show the price performance of TOI in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of TOI is 0.8492 USD. In the past month the price increased by 169.25%. In the past year, price decreased by -58.98%.

ONCOLOGY INSTITUTE INC/THE / TOI Daily stock chart

TOI Latest News, Press Releases and Analysis

News Image
2 months ago - Toi Management, LLC

Florida Blue enhances cancer care for thousands of members

New program aims to improve patient outcomes, experience, and quality of life by streamlining access to affordable and high-quality oncology care

News Image
2 months ago - Toi Management, LLC

Florida Blue enhances cancer care for thousands of members

New program aims to improve patient outcomes, experience, and quality of life by streamlining access to affordable and high-quality oncology care...

News Image
3 months ago - Toi Management, LLC

The Oncology Institute Announces Certification to Administer Pluvicto Therapy in California

TOI will be one of the few community-based practices on the West Coast to offer radiopharmaceuticals in the outpatient setting.

TOI Competitors/Peers

The largest stocks on the US markets in the "Health Care Facilities" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
HCA HCA HEALTHCARE INC 15.23 85.32B
THC TENET HEALTHCARE CORP 13.01 13.79B
BKDT BROOKDALE SENIOR LIVING - BKD 7 11/15/25 N/A 13.68B
UHS UNIVERSAL HEALTH SERVICES-B 13.01 12.75B
EHC ENCOMPASS HEALTH CORP 24.28 10.30B
ENSG ENSIGN GROUP INC/THE 28.14 8.53B
ACHC ACADIA HEALTHCARE CO INC 12.82 4.18B
SGRY SURGERY PARTNERS INC 27.44 3.28B
CON CONCENTRA GROUP HOLDINGS PAR 8.73 2.97B
SEM SELECT MEDICAL HOLDINGS CORP 9.48 2.62B
PACS PACS GROUP INC 19.18 2.26B
ARDT ARDENT HEALTH PARTNERS INC 39.68 2.15B

About TOI

Company Profile

TOI logo image The Oncology Institute, Inc. provides cancer care treatment services. The company is headquartered in Cerritos, California and currently employs 800 full-time employees. The company went IPO on 2020-03-13. The firm manages community-based oncology practices which serve patients at 83 clinic locations across 15 markets and five states throughout the United States. The firm's segment includes patient services, dispensary, and clinical trials & other. Its managed clinics provide a range of medical oncology services, including physician services, in-house infusion and dispensary, radiation, programs like outpatient blood product transfusions, along with 24/7 patient support. The Company, through TOI Clinical Research, LLC (TCR), provides and manages clinical trial services and research for the benefit of cancer patients. The company also provides management services to 14 clinic locations owned by independent oncology practices. The firm and its affiliated providers have contractual relationships with payors serving a variety of patients, including Medicare Advantage (MA), Medicaid, and commercial patients.

Company Info

ONCOLOGY INSTITUTE INC/THE

18000 Studebaker Rd, Suite 800

Cerritos CALIFORNIA US

CEO: Steven Hochberg

Employees: 800

Company Website: https://theoncologyinstitute.com/

Investor Relations: https://investors.theoncologyinstitute.com/

Phone: 15627353226

TOI FAQ

What is the stock price of TOI?

The current stock price of TOI is 0.8492 USD.


What is the symbol for ONCOLOGY INSTITUTE INC/THE stock?

The exchange symbol of ONCOLOGY INSTITUTE INC/THE is TOI and it is listed on the Nasdaq exchange.


On which exchange is TOI stock listed?

TOI stock is listed on the Nasdaq exchange.


Is TOI a good stock to buy?

Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for TOI, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of TOI.


Does TOI stock pay dividends?

TOI does not pay a dividend.


What is the Price/Earnings (PE) ratio of TOI?

TOI does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.78).


What is the Short Interest ratio of TOI stock?

The outstanding short interest for TOI is 0.58% of its float.


TOI Technical Analysis

ChartMill assigns a technical rating of 9 / 10 to TOI. When comparing the yearly performance of all stocks, TOI is one of the better performing stocks in the market, outperforming 96.2% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

TOI Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to TOI. TOI has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

TOI Financial Highlights

Over the last trailing twelve months TOI reported a non-GAAP Earnings per Share(EPS) of -0.78. The EPS increased by -6.85% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -32.07%
ROE -371.14%
Debt/Equity 5.91
Chartmill High Growth Momentum
EPS Q2Q%5.26%
Sales Q2Q%21.78%
EPS 1Y (TTM)-6.85%
Revenue 1Y (TTM)22.29%

TOI Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 84% to TOI. The Buy consensus is the average rating of analysts ratings from 5 analysts.

For the next year, analysts expect an EPS growth of 38.52% and a revenue growth 29.38% for TOI


Ownership
Inst Owners45.02%
Ins Owners2.83%
Short Float %0.58%
Short Ratio0.14
Analysts
Analysts84
Price Target2.04 (140.23%)
EPS Next Y38.52%
Revenue Next Year29.38%